5 Key Takeaways
-
1
Primary vitreoretinal lymphoma (PVRL) often presents with floaters and blurred vision, resembling chronic uveitis.
-
2
Definitive diagnosis of PVRL relies on vitreous biopsy, with multimodal imaging aiding clinical suspicion.
-
3
Intravitreal methotrexate is the most common local therapy for PVRL, though rituximab is an alternative for those intolerant.
-
4
Emerging treatments for PVRL include BTK inhibitors like ibrutinib and zanubrutinib, showing promise in early trials.
-
5
Survival rates for PVRL have improved significantly over the past decades, with increasing therapeutic options available.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.